DNA-encoded library technology expert HitGen just inked a multiyear, multitarget drug discovery deal with Aduro Biotech.
Charles River Laboratories is buying CRO Brains On-Line for €18 million as it further strengthens its offers in CNS early-stage drug research.
RBM is, above all, an opportunity to practice mindfulness in collecting clinical trial data within the site- and patient-centric environment.
WIRB-Copernicus Group has bought Patient Genesis’ eConsent technology, ConsentNow.
PRA will buy health data and analytics expert Symphony Health for $530 million up front as it reports 16% second-quarter service revenue growth.
Icon strengthens real-world evidence offerings by acquiring health research and commercialization company Mapi.
German CRO Evotec is acquiring U.S. counterpart Aptuit in a $300 million deal.
Sarepta offers Exondys 51 outside of the U.S. through a managed access program run by Clinigen, as an EMA decision is expected next year.
Private equity firm EQT is acquiring Certara from Arsenal Capital Partners, a deal that values the CRO at $850 million, Arsenal announced on Tuesday.
Neuroscience-focused digital technology company Ixico just nabbed a contract for imaging clinical trial services from Spanish biotech Araclon.
INC says it is focused on growing its Asia presence with moves and an expansion.